Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation

Polymicrobial infections have been associated with plausible immune mediated diseases, including multiple sclerosis (MS). Virus infection can prime autoimmune T cells specific for central nervous system (CNS) antigens, if virus has molecular mimicry with CNS proteins. On the other hand, infection of irrelevant viruses will induce two types of cytokine responses. Infection with a virus such as lymphocytic choriomeningitis virus (LCMV), can induce interferon (IFN)-α/β production and suppress autoimmunity, while infection with a virus, such as murine cytomegalovirus (MCMV), can activate natural killer (NK), NKT and dendritic cells, resulting in interleukin (IL)-12 and IFN-γ production. These cytokines can cause bystander activation of autoreactive T cells. We established an animal model, where mice infected with vaccinia virus encoding myelin protein can mount autoimmune responses. However, the mice develop clinical disease only after irrelevant immune activation either with complete Freund's adjuvant or MCMV infection. In this review, we propose that a combination of two mechanisms, molecular mimicry and bystander activation, induced by virus infection, can lead to CNS demyelinating diseases, including MS. Viral proteins having molecular mimicry with self-proteins in the CNS can prime genetically susceptible individuals. Once this priming has occurred, an immunologic challenge could result in disease through bystander activation by cytokines.

[1]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[2]  Y. Okuda,et al.  The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis , 2005, Journal of the Neurological Sciences.

[3]  G. Rice,et al.  Interferon β-1a in MS , 2005, Neurology.

[4]  T. Tabira,et al.  Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.

[5]  M. Kamoun,et al.  IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis , 2005, Journal of the Neurological Sciences.

[6]  H. Panitch Influence of infection on exacerbations of multiple sclerosis , 2004, Annals of neurology.

[7]  K. Vandenbroeck,et al.  Inhibiting cytokines of the interleukin‐12 family: recent advances and novel challenges , 2004, The Journal of pharmacy and pharmacology.

[8]  J. Newcombe,et al.  Accumulation of Vα7.2–Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system , 2004 .

[9]  R. Fujinami,et al.  Microorganisms and autoimmunity: making the barren field fertile? , 2003, Nature Reviews Microbiology.

[10]  R. Hurren,et al.  Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells 1 , 2003, The Journal of Immunology.

[11]  M. Kamoun,et al.  Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-β2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System1 , 2003, The Journal of Immunology.

[12]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[13]  T. Yamamura,et al.  Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. , 2003, International immunology.

[14]  C. R. Lankford,et al.  A unique role for IL‐23 in promoting cellular immunity , 2003, Journal of leukocyte biology.

[15]  M. Kamoun,et al.  IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination1 , 2002, The Journal of Immunology.

[16]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[17]  B. Becher,et al.  Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. , 2002, The Journal of clinical investigation.

[18]  R. Welsh,et al.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens , 2002, Nature Immunology.

[19]  J. Libbey,et al.  Are virus infections triggers for autoimmune disease? , 2002, Clinical Microbiology Newsletter.

[20]  A. Fraire,et al.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung , 2001, Nature Immunology.

[21]  T. Yamamura,et al.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.

[22]  M. Ruzek,et al.  NK cell functions restrain T cell responses during viral infections , 2001, European journal of immunology.

[23]  M. V. von Herrath,et al.  Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity. , 2001, Current directions in autoimmunity.

[24]  G. Giaccone,et al.  Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage , 2001 .

[25]  T. Sumida,et al.  Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. , 2001, Arthritis and rheumatism.

[26]  B. Rouse,et al.  Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis , 2001, Journal of Virology.

[27]  R. Welsh Assessing Cd8 T Cell Number and Dysfunction in the Presence of Antigen , 2001, The Journal of experimental medicine.

[28]  T. Yamamura,et al.  Natural killer type 2 bias in remission of multiple sclerosis. , 2001, The Journal of clinical investigation.

[29]  B. Hilliard,et al.  Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[30]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[31]  S. Akira,et al.  IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 , 2000, The Journal of Immunology.

[32]  H. Link,et al.  Multiple sclerosis: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-β , 2000, Journal of Neuroimmunology.

[33]  R. Welsh,et al.  Evolution of the CD8 T-cell repertoire during infections. , 2000, Microbes and infection.

[34]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[35]  A. Stalder,et al.  Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis1 , 2000, The Journal of Immunology.

[36]  R. Welsh,et al.  Consequences of cross-reactive and bystander CTL responses during viral infections. , 2000, Virology.

[37]  J. Newcombe,et al.  Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy1 , 2000, The Journal of Immunology.

[38]  P. Gallo,et al.  Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-b1a. , 2000 .

[39]  F. Spertini,et al.  Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers , 1999, Journal of Neuroimmunology.

[40]  R. Fujinami,et al.  Exacerbation of Viral and Autoimmune Animal Models for Multiple Sclerosis by Bacterial DNA , 1999, Brain pathology.

[41]  R. Fujinami,et al.  Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing–remitting experimental allergic encephalomyelitis , 1999, Journal of Neuroimmunology.

[42]  C. Karp Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.

[43]  A. al‐Sabbagh,et al.  Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion. , 1999, Immunological investigations.

[44]  S. Varga,et al.  Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.

[45]  G. Trinchieri,et al.  Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[46]  C. Biron Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infections☆ , 1998 .

[47]  S. Sriram,et al.  Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-1-mediated Th1 differentiation; an effect of the novel anti-inflammatory drug lisofylline , 1998, Journal of Neuroimmunology.

[48]  D. Paty,et al.  A role for natural killer cells in the immunopathogenesis of multiple sclerosis , 1998, Journal of Neuroimmunology.

[49]  G. Trinchieri,et al.  Role of Interleukin-12 in Primary Influenza Virus Infection , 1998, Journal of Virology.

[50]  L. Blumhardt,et al.  Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis , 1998, Journal of neurology, neurosurgery, and psychiatry.

[51]  J. Papadimitriou,et al.  Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross‐react with virus and cardiac myosin , 1998, Immunology.

[52]  M. Laurent Bistability and the species barrier in prion diseases: stepping across the threshold or not. , 1998, Biophysical chemistry.

[53]  A. Cunningham,et al.  In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? , 1998, The Journal of infectious diseases.

[54]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[55]  M. V. von Herrath,et al.  Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. , 1997, Journal of autoimmunity.

[56]  S. Szabo,et al.  Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells , 1997, The Journal of experimental medicine.

[57]  M. V. von Herrath,et al.  Interferon-γ Is Essential for Destruction of β Cells and Development of Insulin-dependent Diabetes Mellitus , 1997, The Journal of experimental medicine.

[58]  J. Orange,et al.  Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection , 1997 .

[59]  Richard G Richards Interferon beta in multiple sclerosis , 1996, BMJ.

[60]  B. Arnason Interferon beta in multiple sclerosis. , 1996, Neurology.

[61]  J. Orange,et al.  Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. , 1996, Journal of immunology.

[62]  G. Marshall,et al.  Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis , 1996, Neurology.

[63]  R. Fujinami,et al.  Two Models for Multiple Sclerosis: Experimental Allergic Encephalomyelitis and Theiler's Murine Encephalomyelitis Virus , 1996, Journal of neuropathology and experimental neurology.

[64]  B. Weinshenker,et al.  Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.

[65]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[66]  R. Flavell,et al.  Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. , 1995, Immunity.

[67]  Meijuan Zhao,et al.  Interferon-γ-Induced Oligodendrocyte Cell Death: Implications for the Pathogenesis of Multiple Sclerosis , 1995, Molecular medicine.

[68]  J. Orange,et al.  Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration , 1995, The Journal of experimental medicine.

[69]  J. Frelinger,et al.  Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice. , 1995, International immunology.

[70]  T. Sumida,et al.  Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis , 1995, The Journal of experimental medicine.

[71]  J. Leonard,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 , 1995, The Journal of experimental medicine.

[72]  D. Miller,et al.  The British Isles survey of multiple sclerosis in twins , 1994, Neurology.

[73]  P. Allen,et al.  Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.

[74]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  L. Steinman,et al.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.

[76]  Kenneth M. Murphy,et al.  Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent , 1993 .

[77]  T. Bergström,et al.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.

[78]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[79]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[80]  D. Paty,et al.  A population‐based study of multiple sclerosis in twins: Update , 1993 .

[81]  E. D. Robinson,et al.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.

[82]  W. Reed,et al.  Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. , 1992, Immunology.

[83]  M. Nerenberg,et al.  Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response , 1991, Cell.

[84]  L. Kappos,et al.  Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.

[85]  Hiroshi Sato,et al.  Theiler's murine encephalomyelitis virus--characterization of newly isolated viruses from Japanese mouse colonies. , 1990, Jikken dobutsu. Experimental animals.

[86]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[87]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[88]  R. Fujinami,et al.  Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.

[89]  J. Seidman,et al.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. , 1990, Science.

[90]  D. Bourdette,et al.  Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.

[91]  R. Fujinami,et al.  Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures , 1988, Journal of Neuroimmunology.

[92]  H. Kirchner,et al.  Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.

[93]  P. Lebon,et al.  Multiple sclerosis: Involvement of interferons in lesion pathogenesis , 1988, Annals of neurology.

[94]  K. Johnson Treatment of multiple sclerosis with various interferons: The cons , 1988, Neurology.

[95]  Johnson Kp Treatment of multiple sclerosis with various interferons: the cons. , 1988 .

[96]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[97]  D. Paty,et al.  A population-based study of multiple sclerosis in twins. , 1986, The New England journal of medicine.

[98]  R. Fujinami,et al.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.

[99]  R. Hirsch,et al.  Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2 , 1985 .

[100]  A. Alpérovitch,et al.  CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.

[101]  R. Hirsch,et al.  The effect of recombinant alpha2‐interferon on defective natural killer cell activity in multiple sclerosis , 1985, Neurology.

[102]  D. McFarlin,et al.  Expansion of antigen-specific T cells from cerebrospinal fluid of patients with multiple sclerosis , 1983, Journal of Neuroimmunology.

[103]  B. Zweiman,et al.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.

[104]  T. Merigan,et al.  Natural killer cells activity in patients with multiple sclerosis given α interferon , 1983 .

[105]  R. Fujinami,et al.  Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[106]  H T Mount,et al.  Multiple sclerosis and other demyelinating diseases. , 1973, Canadian Medical Association journal.

[107]  R. Fujinami,et al.  TMEV and Neuroantigens: Myelin Genes and Proteins, Molecular Mimicry, Epitope Spreading, and Autoantibody-Mediated Remyelination , 2005, Experimental Models of Multiple Sclerosis.

[108]  M. V. von Herrath Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. , 2002, Current topics in microbiology and immunology.

[109]  M. Herrath Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. , 2002 .

[110]  H. McFarland,et al.  Immunopathogenesis of the multiple sclerosis lesion , 2001, Current neurology and neuroscience reports.

[111]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[112]  J. Altman,et al.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.

[113]  M. Ruzek,et al.  Early cytokine responses to viral infections and their roles in shaping endogenous cellular immunity. , 1998, Advances in experimental medicine and biology.

[114]  M. Oldstone,et al.  Interferon-g Is Essential for Destruction of b Cells and Development of Insulin-dependent Diabetes Mellitus , 1997 .

[115]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[116]  Henry F. McFarland,et al.  Multiple sclerosis : clinical and pathogenetic basis , 1997 .

[117]  M. V. von Herrath,et al.  Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. , 1996, Current topics in microbiology and immunology.

[118]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[119]  R. Sobel T-lymphocyte subsets in the multiple sclerosis lesion. , 1989, Research in immunology.

[120]  L. Liversedge Treatment and management of multiple sclerosis. , 1977, British medical bulletin.

[121]  J. Kurtzke Epidemiology in multiple sclerosis. , 1965, Transactions of the American Neurological Association.